Hepatic surgery for metastases from neuroendocrine tumors

Medicine & Life Sciences

• Neuroendocrine Tumors 100%
• Neoplasm Metastasis 54%
• Liver 45%
• pentetreotide 34%
• Carcinoid Tumor 31%
• Neoplasms 17%
• Transplantation 12%
• Somatostatin 11%
• Anesthetics 9%
• Islet Cell Adenoma 8%
• Somatostatin Receptors 7%
• Central Venous Pressure 6%
• Premedication 6%
• Hepatic Veins 6%
• Morbidity 6%
• Spiral Computed Tomography 6%
• Survival 6%
• Patient Rights 5%
• Hepatectomy 5%
• Bile Ducts 5%
• Mortality 5%
• Liver Transplantation 5%
• Allografts 4%
• Therapeutics 4%
• Hemodynamics 4%
• Referral and Consultation 4%
• Heart Failure 4%
• Hemorrhage 3%
• Physicians 3%
• Costs and Cost Analysis 3%
• Bone and Bones 3%
• Recurrence 3%
• Population 2%